BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 29282357)

  • 1. Risk factors for arterial versus venous thrombosis in polycythemia vera: a single center experience in 587 patients.
    Cerquozzi S; Barraco D; Lasho T; Finke C; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
    Blood Cancer J; 2017 Dec; 7(12):662. PubMed ID: 29282357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leukocytosis at diagnosis and the risk of subsequent thrombosis in patients with low-risk essential thrombocythemia and polycythemia vera.
    Gangat N; Wolanskyj AP; Schwager SM; Hanson CA; Tefferi A
    Cancer; 2009 Dec; 115(24):5740-5. PubMed ID: 19806641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Marchioli R; Leone G; Barbui T;
    Haematologica; 2008 Mar; 93(3):372-80. PubMed ID: 18268279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic impact of bone marrow fibrosis in polycythemia vera: validation of the IWG-MRT study and additional observations.
    Barraco D; Cerquozzi S; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Tefferi A
    Blood Cancer J; 2017 Mar; 7(3):e538. PubMed ID: 28282034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia.
    Ann Intern Med; 1995 Nov; 123(9):656-64. PubMed ID: 7574220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
    Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
    Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leukocytosis is a risk factor for recurrent arterial thrombosis in young patients with polycythemia vera and essential thrombocythemia.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Gerli G; Guglielmelli P; Pieri L; Scognamiglio F; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
    Am J Hematol; 2010 Feb; 85(2):97-100. PubMed ID: 20052743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombotic Risk Factor in Polycythemia Vera Patients: An Observational Study.
    Segura-Díaz A; Stuckey R; Florido Y; Sobas M; Álvarez-Larrán A; Ferrer-Marín F; Pérez-Encinas M; Carreño-Tarragona G; Fox ML; Tazón Vega B; Cuevas B; López Rodríguez JF; Sánchez-Farías N; González-Martín JM; Gómez-Casares MT; Bilbao-Sieyro C;
    Thromb Haemost; 2024 Jul; 124(7):669-675. PubMed ID: 38190984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombohemorrhagic events, disease progression, and survival in polycythemia vera and essential thrombocythemia: a retrospective survey in Miyazaki prefecture, Japan.
    Kamiunten A; Shide K; Kameda T; Sekine M; Kubuki Y; Ito M; Toyama T; Kawano N; Marutsuka K; Maeda K; Takeuchi M; Kawano H; Sato S; Ishizaki J; Akizuki K; Tahira Y; Shimoda H; Hidaka T; Yamashita K; Matsuoka H; Shimoda K
    Int J Hematol; 2018 Jun; 107(6):681-688. PubMed ID: 29488167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arterial stenosis and atherothrombotic events in polycythemia vera and essential thrombocythemia.
    Cucuianu A; Stoia M; Farcaş A; Dima D; Zdrenghea M; Paţiu M; Olinic D; Petrov L
    Rom J Intern Med; 2006; 44(4):397-406. PubMed ID: 18386616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic complications of polycythemia vera.
    Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
    Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of thrombosis and bleeding complications in patients with polycythemia vera: a Turkish retrospective study.
    Yesilova AM; Yavuzer S; Yavuzer H; Cengiz M; Toprak ID; Hanedar E; Ar MC; Baslar Z
    Int J Hematol; 2017 Jan; 105(1):70-78. PubMed ID: 27699575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Risk factors for recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia].
    Han X; Bai BB; Wang CJ; Zhao S; Chen Y
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jan; 40(1):17-23. PubMed ID: 30704223
    [No Abstract]   [Full Text] [Related]  

  • 14. Leukocytosis in polycythemia vera and splenomegaly in essential thrombocythemia are independent risk factors for hemorrhage.
    Chou YS; Gau JP; Yu YB; Pai JT; Hsiao LT; Liu JH; Hong YC; Liu CY; Yang CF; Chen PM; Chiou TJ; Tzeng CH
    Eur J Haematol; 2013 Mar; 90(3):228-36. PubMed ID: 23281576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucocytosis in polycythaemia vera predicts both inferior survival and leukaemic transformation.
    Gangat N; Strand J; Li CY; Wu W; Pardanani A; Tefferi A
    Br J Haematol; 2007 Aug; 138(3):354-8. PubMed ID: 17614822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polycythemia vera--a case report and discussion on pathogenic mechanisms of increased thrombosis.
    Gumina RJ; Foley DA; Tefferi A; Rooke TW; Shields RC
    Angiology; 2002; 53(5):587-91. PubMed ID: 12365868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombosis in patients with post-polycythemia vera myelofibrosis: incidence and risk factors.
    Teng G; Zhou Y; Zhang Y; Hu N; Liu T; Han Y; Gao C; Zhang L; Bai J
    Thromb Res; 2022 Apr; 212():38-43. PubMed ID: 35219930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
    Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Vannucchi AM; Antonioli E; Gisslinger H; Buxhofer-Ausch V; Finazzi G; Gangat N; Tefferi A; Barbui T
    Blood; 2011 Jun; 117(22):5857-9. PubMed ID: 21490340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
    Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
    Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leukocytosis as a major thrombotic risk factor in patients with polycythemia vera.
    Landolfi R; Di Gennaro L; Barbui T; De Stefano V; Finazzi G; Marfisi R; Tognoni G; Marchioli R;
    Blood; 2007 Mar; 109(6):2446-52. PubMed ID: 17105814
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.